MMWR Morb Mortal Wkly Rep. 2004 Feb 27;53(7):145-8.
During 1980-1999, asthma prevalence, morbidity, and mortality increased among U.S. adults. These annual rates were higher among certain racial/ethnic minority populations than among whites. In addition, racial/ethnic minority populations reported higher use of emergency departments (EDs) and doctors' offices for asthma treatment than whites. To assess asthma prevalence and asthma-control characteristics among racial/ethnic populations, CDC analyzed 2002 data from the Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes the results of that analysis, which indicated that among the estimated 16 million (7.5%) U.S. adults with asthma, self-reported current asthma prevalence among racial/ethnic minority populations ranged from 3.1% to 14.5%, compared with 7.6% among whites. Comprehensive state-specific asthma surveillance data are necessary to identify disparities in asthma prevalence and asthma-control characteristics among racial/ethnic populations and to develop targeted public health interventions.
1980年至1999年间,美国成年人中哮喘的患病率、发病率和死亡率均有所上升。某些种族/族裔少数群体的这些年发病率高于白人。此外,种族/族裔少数群体因哮喘治疗而前往急诊科(ED)和医生办公室就诊的频率高于白人。为评估不同种族/族裔人群中的哮喘患病率和哮喘控制特征,美国疾病控制与预防中心(CDC)分析了行为危险因素监测系统(BRFSS)2002年的数据。本报告总结了该分析结果,结果表明,在美国估计1600万(7.5%)患有哮喘的成年人中,种族/族裔少数群体自我报告的当前哮喘患病率在3.1%至14.5%之间,而白人中的这一比例为7.6%。全面的各州特定哮喘监测数据对于识别不同种族/族裔人群中哮喘患病率和哮喘控制特征的差异以及制定有针对性的公共卫生干预措施至关重要。